Gland Pharma Ltd (GLAND)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 1914.80
% Change: 2.40% (Prev Close: 1870.00)

Volume: 4,31,248
% Change: 444.84% (Prev Volume: 79,151)

Delivery: 3,67,978
Delivery % : 85.33
% Change: 642.61% (Prev Delivery: 49,552)

Turnover: 8,232 Lacs
% Change: 454.14% (Prev Turnover: 1,486)

πŸ’Ή EOD Valuation

P/E Ratio: 40.96
P/B Ratio: 3.45
Market Cap: 31556 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: GLAND
Market Cap: 30834 Rs. Cr.
Face Value: 1.00 Rs.

52 Week High: 2131.00
52 Week Low: 1200.00

All-Time High: 4350.00 Rs.
All-Time Low: 861.00 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-4.47% | 14.30% | 14.33% | -0.54% | -8.78%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 51.83%

Change (3Y | 1Y): -6.04% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 7.39%

Change (3Y | 1Y): -2.02% | 0.49%

DII Holding

DII Holding: 32.86%

Change (3Y | 1Y): 15.50% | -0.41%

Public Holding: 7.93%

🏦 Financial Strength

Debt to Equity: 0.03
Debt: 313.73 Rs. Cr.

Book Value: 555.41 Rs.
Current Ratio: 4.33
Interest Coverage: 25.17
Free Cash Flow: 520.90 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: -2.34%

Sales Growth Qtr (YOY | QoQ):
7.41% | 5.66%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
16.36% | 8.47% | -2.34%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: 6.66%

Profit Growth Qtr (YOY | QoQ):
49.89% | 15.51%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
-1.69% | -16.73% | 6.66%

EPS Rs.

EPS (TTM): 46.75 Rs.

EPS Qtr (Last Year | Latest):
8.73 Rs. | 13.08 Rs.

EPS Annual (Last Annual | Annual March):
46.90 Rs. | 42.40 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
-2.89% | -16.81%

Net Profit Rs. Cr.

Net Profit (TTM): 770.24 Rs. Cr.

Net Profit (Annual - March): 698.53 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
143.76| 186.54 | 215.48

EBITDA Rs. Cr.

EBITDA (Quarter): 425.29 Rs. Cr.
EBITDA (Previous Yr Ql): 315.83 Rs. Cr.

EBITDA (Annual - March): 1481.33 Rs. Cr.
EBITDA (Previous Annual): 1502.71 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
6.58% | -5.04%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 23.99%

OPM Qtr (Previous | Current):
24.39% | 24.43%

OPM Annual (5 Yrs | Last Yr | March):
28.28% | 23.53% | 22.59%

Return on Equity %

ROE: 7.81%

ROE (5 Yrs | 3 Yrs | Last Yr):
12.44% | 9.22% | 9.26%

Return on Capital Employed %

ROCE: 11.89%

ROCE (5 Yrs | 3 Yrs | Last Yr):
18.60% | 13.41% | 13.58%

Return on Assets %

ROA (TTM): 6.41%

ROA (5 Yrs | 3 Yrs | Last Yr):
11.99% | 8.08% | 7.96%

PEG Ratio: -2.39
Dividend Yield: 0.96%

PE 3 Yrs: 37.11
PE 5 Yrs: 39.99

Dividend Yield: 0.96%

πŸ‘₯ Company

Gland Pharma Ltd

GLAND

Promoter Holding: %